» Articles » PMID: 24857025

Delayed Union and Nonunions: Epidemiology, Clinical Issues, and Financial Aspects

Overview
Journal Injury
Publisher Elsevier
Specialty Emergency Medicine
Date 2014 May 27
PMID 24857025
Citations 246
Authors
Affiliations
Soon will be listed here.
Abstract

Fracture healing is a critically important clinical event for fracture patients and for clinicians who take care of them. The clinical evaluation of fracture healing is based on both radiographic findings and clinical findings. Risk factors for delayed union and nonunion include patient dependent factors such as advanced age, medical comorbidities, smoking, non-steroidal anti-inflammatory use, various genetic disorders, metabolic disease and nutritional deficiency. Patient independent factors include fracture pattern, location, and displacement, severity of soft tissue injury, degree of bone loss, quality of surgical treatment and presence of infection. Established nonunions can be characterised in terms of biologic capacity, deformity, presence or absence of infection, and host status. Hypertrophic, oligotrophic and atrophic radiographic appearances allow the clinician to make inferences about the degree of fracture stability and the biologic viability of the fracture fragments while developing a treatment plan. Non-unions are difficult to treat and have a high financial impact. Indirect costs, such as productivity losses, are the key driver for the overall costs in fracture and non-union patients. Therefore, all strategies that help to reduce healing time with faster resumption of work and activities not only improve medical outcome for the patient, they also help reduce the financial burden in fracture and non-union patients.

Citing Articles

Mesenchymal stem cells therapy for the treatment of non-union fractures: a systematic review and meta-analysis.

Cui C, Lin F, Xia L, Zhang X BMC Musculoskelet Disord. 2025; 26(1):245.

PMID: 40069694 PMC: 11900535. DOI: 10.1186/s12891-025-08365-w.


Development of a novel rat long-bone nonunion model and efficacy evaluation of a prostaglandin EP4 selective agonist (AKDS001) combined with iliac bone grafting.

Tateiwa D, Nishida M, Kodama J, Hirai H, Nakagawa S, Ukon Y Bone Joint Res. 2025; 14(3):166-175.

PMID: 40028789 PMC: 11873957. DOI: 10.1302/2046-3758.143.BJR-2024-0220.R1.


Deer antler velvet (Cervus elaphus sibiricus) promotes fracture healing via partial BMP2-Smad mediated osteoblast differentiation.

Gu J, Chae M, Choi J, Duc T, Son C, Lee E J Orthop Surg Res. 2025; 20(1):70.

PMID: 39833827 PMC: 11744865. DOI: 10.1186/s13018-024-05426-z.


A review of electroacupuncture in bone repair: Mechanisms and clinical implications.

Gao Y, Wang Y, Zhao D, Wen Q, Shi H, Wang S Medicine (Baltimore). 2025; 103(47):e40725.

PMID: 39809159 PMC: 11596701. DOI: 10.1097/MD.0000000000040725.


[Influencing fracture healing by specific osteoporosis medications].

Stumpf U, Schmidmaier R, Taipaleenmaki H, Bocker W, Kurth A, Hesse E Z Rheumatol. 2025; 84(2):107-112.

PMID: 39806104 DOI: 10.1007/s00393-024-01610-y.